GlaxoSmithKline Czech Republic made a net profit of CZK 65.4 mil in 2017, up 72% compared to the previous year. Total sales reached CZK 2,897 mil, which is down 14.6% when compared to the previous year.
Historically, between 2003 and 2017, the company’s net profit reached a high of CZK 240 mil in 2011 and a low of CZK -7.67 mil in 2006. Over the last decade the firm's net profit increased by an average of 0% a year.
Sales have fallen by 4.26% a year on average since 2007. They reached a high of CZK 6,186 mil in 2009 and a low of CZK 2,492 mil in 2003.
The company has been operating with an average EBITDA margin of 2.92% in the last 5 years and average net margin of 2.06%. The firm generated an average return on invested capital of 6.67% for its shareholders over the last five years.
You can see all the company’s data at GlaxoSmithKline Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
